GlaxoSmithKline PLC ADR (GSK) — the earnings record
Computed on 2026-09-18 from the vendor's per-print history with the Print Record's method — no desk-written read yet. An investment research diary, not advice.
The record at a glance
Reactions across the covered prints span -3.8% to +3.1% — the beat column and the reaction column frequently disagree, which is the whole reason the record scores them separately. The street carries est EPS $1.37 · est revenue ~$11.97B into the next print.
Print by print
| Date | EPS | Revenue | |
|---|---|---|---|
| Jul 26 | 2026-07-28 | ✓ beat | ✓ beat |
| Apr 26 | 2026-04-29 | ✓ beat | ✓ beat |
| Feb 26 | 2026-02-04 | ✓ beat | ✓ beat |
| Oct 25 | 2025-10-29 | ✓ beat | ✓ beat |
| Jul 25 | 2025-07-30 | ✓ beat | ✓ beat |
| Apr 25 | 2025-04-30 | ✓ beat | ✓ beat |
| Feb 25 | 2025-02-05 | ✓ beat | ✓ beat |
| Oct 24 | 2024-10-30 | ✓ beat | ✗ miss |
| Jul 24 | 2024-07-31 | ✓ beat | ✓ beat |
| May 24 | 2024-05-01 | ✓ beat | ✓ beat |
Report-day close to the close three sessions later on adjusted closes, ±3% bands — the same method as every hand-written card; the Print Record method explains the bands. No reaction chart, metric line or behavior read exists for GSK yet.
FAQ · from the current data · as of 2026-09-18
Quick answers
How often does GlaxoSmithKline PLC ADR beat earnings estimates?
Across the last 10 covered prints (as of the 2026-09-18 card), GlaxoSmithKline PLC ADR beat EPS estimates 10 of 10 times and revenue estimates 9 of 10 times, with 9 double beats.
How does GSK stock react to earnings?
Measured close-of-print-day to the close three sessions later: 1 of the last 10 prints resolved up (beyond +3%), 6 flat, 3 down — reactions spanning -3.8% to +3.1%. Beat-or-miss and reaction are scored separately because they frequently disagree.
What was GSK's biggest earnings reaction?
-3.8% over the three sessions after the Jul 26 print (2026-07-28).
When does GlaxoSmithKline PLC ADR report earnings next?
2026-10-28 (2026-10-28 · est EPS $1.37 · est revenue ~$11.97B). This record is computed from the vendor's per-print history with the Print Record's method; a desk-written card for GSK does not exist yet. An investment research diary, not advice.
Related in the Closelook universe
then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- LLY Eli Lilly and Companyindustry
- ORNAV.HE Orion Oyj Aindustry
- ORNBV.HE Orion Oyj Bindustry
- SAN.PA Sanofi SAindustry
- NVO Novo Nordisk A/Sindustry
- AMGN Amgen Incindustry
- GILD Gilead Sciences Incindustry
- MRK Merck & Company Incindustry
- PFE Pfizer Incindustry
- BIIB Biogen Incindustry
- ABBV AbbVie Incindustry
- JNJ Johnson & Johnsonindustry
- OGN Organon & Coindustry
- BMY Bristol-Myers Squibb Companyindustry
- SNY Sanofi ADRindustry
- VIRP.PA Virbac SAindustry
- AZN AstraZeneca PLCindustry
- ARGX argenx NV ADRsector
- ONC BeiGene, Ltd.sector
- MEDP Medpace Holdings Incsector